Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 doesn't make alopecia areata worse.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Social media data can help track and predict COVID-19 symptoms and trends.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may harm male fertility and damage the reproductive system.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

PCOS is a hereditary disorder that can lead to diabetes and heart disease if not treated early.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.